After a proposal of £50 billion ($68 billion) was rejected, consumer goods giant Unilever NSE -0.57% indicated a persistent interest in a consumer health care unit jointly held by pharmaceutical companies GlaxoSmithKline and Pfizer NSE -0.66 percent.
"GSK Consumer Healthcare would be a strong strategic fit," Unilever said in a statement released in the aftermath of the buyout news over the weekend.
"We are dedicated to accelerating the companys growth and shifting the portfolio into higher-growth areas," Unilever added.
After a proposal of £50 billion ($68 billion) was rejected, consumer goods giant Unilever NSE -0.57% indicated a persistent interest in a consumer health care unit jointly held by pharmaceutical companies GlaxoSmithKline and Pfizer NSE -0.66 percent.
"GSK Consumer Healthcare would be a strong strategic fit," Unilever said in a statement released in the aftermath of the buyout news over the weekend.
"We are dedicated to accelerating the companys growth and shifting the portfolio into higher-growth areas," Unilever added.
Facebook
Whatsapp
Gmail